search
Back to results

Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment

Primary Purpose

Mild Cognitive Impairment, Alzheimer Disease

Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Lighting Intervention Blue light
Lighting Intervention Green light
Sponsored by
Icahn School of Medicine at Mount Sinai
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Mild Cognitive Impairment

Eligibility Criteria

55 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • mild cognitive impairment
  • age matched healthy control
  • macular pigment density either < 0.3 or > 0.5

Exclusion Criteria:

  • extensive brain vascular disease
  • Parkinson's disease
  • bipolar disorder
  • seasonal depression
  • diabetes
  • high blood pressure
  • obstructing cataracts
  • macular degeneration
  • diabetic retinopathy
  • use of melatonin supplements
  • use of beta blockers
  • use of sleep medications
  • use of antidepressant medication

Sites / Locations

  • Light and Health Research Center at Mount SinaiRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Experimental

Arm Label

Lighting Intervention Blue

Lighting Intervention Green

Arm Description

Blue light (λmax = 451 nm) on and off axis

Green light (λmax = 522 nm) on and off axis

Outcomes

Primary Outcome Measures

Change in melatonin levels
Saliva samples will be collected for melatonin analysis

Secondary Outcome Measures

Full Information

First Posted
June 2, 2022
Last Updated
May 24, 2023
Sponsor
Icahn School of Medicine at Mount Sinai
search

1. Study Identification

Unique Protocol Identification Number
NCT05411822
Brief Title
Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment
Official Title
Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment and Alzheimer's Disease
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
September 28, 2021 (Actual)
Primary Completion Date
May 31, 2024 (Anticipated)
Study Completion Date
May 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Icahn School of Medicine at Mount Sinai

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this research study is to investigate the relationship between light, the thickness of the pigment at the back of your eye, melatonin levels, and memory. The study will investigate whether changing light distribution pattern from "on-axis"' (i.e., directed along the eye's visual axis to the fovea) to "off-axis" (i.e., directed on the periphery of the eye's visual axis) impact melatonin suppression in 24 mild cognitive impairment participants and 24 healthy, age-matched controls.
Detailed Description
Eligible enrolled subjects will be exposed to 4 different lighting conditions in addition to one dark control condition. There will be 5 study session and each one will last for 90 minutes and will be separated by one week. Subjects will collect 3 saliva samples, each one 30 minutes apart for melatonin levels during each study session.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Mild Cognitive Impairment, Alzheimer Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Participant
Allocation
Randomized
Enrollment
48 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Lighting Intervention Blue
Arm Type
Experimental
Arm Description
Blue light (λmax = 451 nm) on and off axis
Arm Title
Lighting Intervention Green
Arm Type
Experimental
Arm Description
Green light (λmax = 522 nm) on and off axis
Intervention Type
Device
Intervention Name(s)
Lighting Intervention Blue light
Intervention Description
Custom made lighting fixture that will deliver the blue lighting intervention
Intervention Type
Device
Intervention Name(s)
Lighting Intervention Green light
Intervention Description
Custom made lighting fixture that will deliver the green lighting intervention
Primary Outcome Measure Information:
Title
Change in melatonin levels
Description
Saliva samples will be collected for melatonin analysis
Time Frame
one sample will be collected every 30 minutes during each 90 minute study session up to 5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
55 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: mild cognitive impairment age matched healthy control macular pigment density either < 0.3 or > 0.5 Exclusion Criteria: extensive brain vascular disease Parkinson's disease bipolar disorder seasonal depression diabetes high blood pressure obstructing cataracts macular degeneration diabetic retinopathy use of melatonin supplements use of beta blockers use of sleep medications use of antidepressant medication
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Barbara Plitnick, BSN
Phone
518 366-9306
Email
barbara.plitnick@mountsinai.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Mariana Figueiro, PhD
Organizational Affiliation
Icahn School of Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
Light and Health Research Center at Mount Sinai
City
Menands
State/Province
New York
ZIP/Postal Code
12204
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Barbara Plitnick, BSN
Phone
518-366-9306
Email
barbara.plitnick@mountsinai.org
First Name & Middle Initial & Last Name & Degree
Mariana Figueiro, PhD

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Understanding Circadian Responses to Light in Persons With Mild Cognitive Impairment

We'll reach out to this number within 24 hrs